O
Olav Spigset
Researcher at Norwegian University of Science and Technology
Publications - 342
Citations - 8344
Olav Spigset is an academic researcher from Norwegian University of Science and Technology. The author has contributed to research in topics: Pregnancy & Medicine. The author has an hindex of 44, co-authored 321 publications receiving 7197 citations. Previous affiliations of Olav Spigset include Borregaard.
Papers
More filters
Journal ArticleDOI
Incidence of fatal adverse drug reactions: a population based study
TL;DR: Haemorrhages were seen in a majority of the FADRs; antithrombotic agents or NSAIDs were implicated in most of these events; preventive measures should be taken to reduce the number of deaths caused by drugs.
Journal ArticleDOI
Medication use in pregnancy: a cross-sectional, multinational web-based study.
Angela Lupattelli,Olav Spigset,Michael J. Twigg,Ksenia Zagorodnikova,A C Mårdby,Myla E Moretti,Mariola Drozd,Alice Panchaud,Katri Hämeen-Anttila,André Rieutord,R. Gjergja Juraški,Marina Odalovic,Debra Kennedy,Gorazd Rudolf,Herbert Juch,Anneke Passier,Ingunn Björnsdóttir,Hedvig Nordeng,Hedvig Nordeng +18 more
TL;DR: The majority of women in Europe, North America, South America and Australia used at least one medication during pregnancy, and there was a substantial inter-region variability in the types of medication used.
Journal ArticleDOI
The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: A modified Delphi study
TL;DR: The NORGEP criteria may serve as rules of thumb for general practitioners related to their prescribing practice for elderly patients, and as a tool for evaluating the quality of GPs’ prescribing in settings where access to clinical information for individual patients is limited, e.g. in prescription databases and quality improvement interventions.
Journal ArticleDOI
Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
Karin Hedenmalm,Olav Spigset +1 more
TL;DR: Based on sales data and spontaneous reporting of adverse drug reactions in Sweden, the risk of agranulocytosis with dipyrone seems to be considerably higher than the previously estimated risks.
Journal ArticleDOI
Prevalence of Diabetes and Impaired Glucose Tolerance in Patients Treated With Clozapine Compared With Patients Treated With Conventional Depot Neuroleptic Medications
TL;DR: Subjects treated with clozapine were more often classified as having type 2 diabetes mellitus or IGT compared with subjects in the control group, whereas the 2 groups did not differ with respect to body weight, body mass index, or prevalence of Diabetes mellitus in first-degree relatives.